-
261
Dietary Intake of Micronutrients and Disease Severity in Patients with Amyotrophic Lateral Sclerosis
Published 2023-05-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
262
POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
Published 2022-11-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
263
TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
Published 2022-12-01Subjects: “…Amyotrophic lateral sclerosis…”
Get full text
Article -
264
Insight into endoplasmic reticulum-mitochondria contacts in human amyotrophic lateral sclerosis
Published 2024-01-01Get full text
Article -
265
Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis
Published 2023-05-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
266
Lingual fasciculation: A point of call for the diagnosis of amyotrophic lateral sclerosis
Published 2023-06-01Subjects: Get full text
Article -
267
Short-term outcome of plasma adsorption therapy in amyotrophic lateral sclerosis
Published 2023-01-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
268
Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
Published 2021-09-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
269
Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives
Published 2023-07-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
270
How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis
Published 2020-11-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
271
A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis
Published 2022-01-01Subjects: “…amyotrophic lateral sclerosis (ALS)…”
Get full text
Article -
272
Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage
Published 2024-03-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
273
Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosis
Published 2022-10-01Subjects: “…Amyotrophic lateral sclerosis…”
Get full text
Article -
274
Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia
Published 2022-11-01Subjects: “…Amyotrophic lateral sclerosis…”
Get full text
Article -
275
Association of cerebral spinal fluid copper imbalance in amyotrophic lateral sclerosis
Published 2022-11-01“…A plethora of environmental risk factors has been persistently implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), including metal/metalloids. …”
Get full text
Article -
276
ANXA11 mutations are associated with amyotrophic lateral sclerosis–frontotemporal dementia
Published 2022-09-01Subjects: Get full text
Article -
277
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
Published 2020-12-01“…Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disease that leads to a loss of muscle control due to nerve cells being affected in the brain and spinal cord. …”
Get full text
Article -
278
The usage and advantages of several common amyotrophic lateral sclerosis animal models
Published 2024-02-01Subjects: “…amyotrophic lateral sclerosis…”
Get full text
Article -
279
Venous blood parameters in determination of respiratory impairment in amyotrophic lateral sclerosis
Published 2023-09-01“…Abstract This study aimed to investigate the relationship between venous blood parameters and respiratory functions in patients with amyotrophic lateral sclerosis (ALS) and develop a model to predict respiratory impairment for individual patients with ALS. …”
Get full text
Article -
280
MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis
Published 2022-11-01“…Abstract Objective MicroRNAs are promising biomarkers of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), but discrepant results between studies have so far hampered their use in clinical trials. …”
Get full text
Article